Charles River Associates (CRA) Announces Fourth-Quarter and Full-Year Fiscal 2013 Financial Results
Portfolio Positioned for Continued Growth
Board Expands Share Repurchase Authorization
Revenue for the fourth quarter of fiscal 2013 increased to
Net income for the fourth quarter of fiscal 2013 was
The Adjusted EBITDA for the fourth quarter of fiscal 2013 was
A complete reconciliation between revenue, net income/loss and net income/loss per diluted share, and the calculation of Adjusted EBITDA, on a GAAP and non-GAAP basis, for the fourth quarters of fiscal 2013 and fiscal 2012, and for the full 2013 and 2012 fiscal years, is provided in the financial tables at the end of this release.
Management Comments
“CRA’s fourth quarter performance was driven by companywide utilization of 80% and solid contributions from across our portfolio,” said
“On a year-over-year, non-GAAP basis, our portfolio delivered 12.6% revenue growth in the fourth quarter. Six practice areas, in particular, delivered even stronger year-over-year revenue growth: Antitrust & Competition Economics, Auctions & Competitive Bidding, Financial Economics, Intellectual Property, Life Sciences, and Transfer Pricing.”
“Selling, general and administrative operations also performed well and helped to improve our efficiency gains during the fourth quarter. On a non-GAAP basis, fourth quarter SG&A expenses, after adjusting for commissions to non-employee experts, decreased to 18.6% from 19.3% a year ago. For fiscal 2013, non-GAAP SG&A expenses, after adjusting for commissions to non-employee experts, decreased to 19.0%, compared with 21.1% in fiscal 2012.”
“As a result of our improved operating performance and collection efforts, cash and cash equivalents increased to
Outlook
“On the heels of a strong second half of fiscal 2013, we are encouraged by our prospects for increasing profitability and revenue growth in fiscal 2014, both organically and through strategic hires. We are pleased with the level of lead flow activity and the quality of the conversion rate into revenue generating projects. While we remain cautious about our clients’ spending patterns, the broad-based demand for our services and the solid foundation we have put in place give us optimism that the momentum experienced during the past six months will continue into fiscal 2014,” Maleh concluded.
Share Repurchase Expansion
CRA also announced today that its Board of Directors has authorized an expanded share repurchase program of up to
CRA will finance the existing and expanded repurchase programs with available cash. CRA may repurchase shares in open market purchases or in privately negotiated transactions in accordance with applicable insider trading and other securities laws and regulations. The timing and extent to which CRA repurchases shares under these programs will depend upon market conditions and other corporate considerations as may be considered in its sole discretion.
“CRA has the financial resources available to fund the existing and expanded share repurchase program while continuing to execute its corporate strategy,” said
CRA also announced today that its Board of Directors has authorized management to enter into a Rule 10b5-1 plan on behalf of CRA. CRA expects that the plan, once effective, will be in place through the end of 2014. The plan will allow CRA to repurchase its shares at times when it otherwise might be prevented from doing so under insider trading laws or because of self-imposed trading blackout periods. A broker selected by CRA will have the authority under the terms and limitations specified in the plan to repurchase shares on the Company’s behalf in accordance with the terms of the plan. Because the repurchases under the plan are subject to certain pricing parameters, there is no guarantee as to the exact number of shares that will be repurchased under the plan, or that there will be any repurchases pursuant to the plan.
Conference Call Information and Prepared CFO Remarks
CRA will host a conference call this morning at
In combination with this press release, CRA is providing prepared remarks by its CFO
About
Charles River Associates® is a global consulting firm specializing in litigation, regulatory, and financial consulting, and management consulting. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in
Non-GAAP Financial Measures
In addition to reporting its financial results in accordance with U.S. generally accepted accounting principles, or GAAP, the Company has also provided in this release non-GAAP financial information. The Company believes the use of non-GAAP measures in addition to GAAP measures is an additional useful method of evaluating its results of operations. The Company believes that presenting its financial results excluding certain restructuring costs, certain non-cash expenses, and the results of the Company’s NeuCo subsidiary is important to investors and management because it is more indicative of the Company’s ongoing operating results and financial condition. These non-GAAP financial measures should be considered in conjunction with, but not as a substitute for, the financial information presented in accordance with GAAP, and the expected results calculated in accordance with GAAP and reconciliations to those expected results should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.
Specifically, for the fourth quarter and full-year of fiscal 2013, the Company has excluded NeuCo’s results. For the fourth quarter and full year of fiscal 2012, the Company has excluded certain restructuring costs, a non-cash goodwill impairment charge, and NeuCo’s results. In calculating “Adjusted EBITDA” on a GAAP and non-GAAP basis, the Company has excluded the following non-cash expenses: depreciation and amortization, share-based compensation expenses, and amortization of forgivable loans. The calculation of Adjusted EBITDA on a non-GAAP basis for the periods presented includes all of the adjustments generally applicable to that period as described above in this paragraph.
Statements in this press release concerning the future business, operating results and financial condition of the Company, and statements using the terms “believes,” “expects,” “should,” “prospects,” “encouraged,” “optimism,” “opportunities,” “momentum…will continue,” “positioned for continued growth,” or similar expressions are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management's current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by the Company include, among others, the Company’s restructuring costs and attributable annual cost savings, changes in the Company’s effective tax rate, share dilution from the Company’s stock-based compensation, dependence on key personnel, attracting, recruiting and retaining qualified consultants, dependence on outside experts, utilization rates, completing acquisitions and factors related to its completed acquisitions, including integration of personnel, clients and offices, and unanticipated expenses and liabilities, the risk of impairment write downs to the Company’s intangible assets, including goodwill, if the Company’s enterprise value declines below certain levels, risks associated with acquisitions it may make in the future, risks inherent in international operations, the performance of NeuCo, changes in accounting standards, rules and regulations, changes in the law that affect the Company’s practice areas, management of new offices, the potential loss of clients, the ability of customers to terminate the Company’s engagements on short notice, dependence on the growth of the Company’s management consulting practice, the unpredictable nature of litigation-related projects, the ability of the Company to integrate successfully new consultants into its practice, the Company’s ability to collect on forgivable loans should any become due, general economic conditions, intense competition, risks inherent in litigation, and professional liability. Further information on these and other potential factors that could affect the Company’s financial results is included in the Company’s periodic filings with the
| CRA INTERNATIONAL, INC. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS INCLUDING A RECONCILIATION TO NON-GAAP RESULTS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FOR THE QUARTER ENDED DECEMBER 28, 2013 COMPARED TO THE QUARTER ENDED DECEMBER 29, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarter Ended December 28, 2013 | Quarter Ended December 29, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GAAP Results |
GAAP % of Revenues |
Adjustments to GAAP Results (NeuCo) (1) |
Non-GAAP Results |
Non-GAAP |
GAAP Results |
GAAP % of Revenues |
Adjustments to GAAP Results (Restructuring) (2) |
Adjustments to |
Adjustments to GAAP Results (NeuCo) (1) |
Non-GAAP Results |
Non-GAAP % of Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Revenues |
$ | 75,672 | 100.0 | % | $ | 1,347 | $ | 74,325 | 100.0 | % | $ | 67,533 | 100.0 | % | $ | - | $ | - | $ | 1,546 | $ | 65,987 | 100.0 | % | |||||||||||||||||||||||||||||||||||
|
Costs of services |
51,628 | 68.2 | % | 339 | 51,289 | 69.0 | % | 44,271 | 65.6 | % | 390 | - | 321 | 43,560 | 66.0 | % | |||||||||||||||||||||||||||||||||||||||||||
| Gross profit (loss) | 24,044 | 31.8 | % | 1,008 | 23,036 | 31.0 | % | 23,262 | 34.4 | % | (390 | ) | - | 1,225 | 22,427 | 34.0 | % | ||||||||||||||||||||||||||||||||||||||||||
|
Selling, general and administrative expenses |
16,966 | 22.4 | % | 942 | 16,024 | 21.6 | % | 15,217 | 22.5 | % | (209 | ) | 225 | 775 | 14,426 | 21.9 | % | ||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 1,619 | 2.1 | % | - | 1,619 | 2.2 | % | 1,610 | 2.4 | % | 207 | - | 1 | 1,402 | 2.1 | % | |||||||||||||||||||||||||||||||||||||||||||
| Goodwill impairment | - | 0.0 | % | - | - | 0.0 | % | 71,394 | 105.7 | % | - | 71,394 | - | - | 0.0 | % | |||||||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | 5,459 | 7.2 | % | 66 | 5,393 | 7.3 | % | (64,959 | ) | -96.2 | % | (388 | ) | (71,619 | ) | 449 | 6,599 | 10.0 | % | ||||||||||||||||||||||||||||||||||||||||
| Interest and other income (expense), net | (238 | ) | -0.3 | % | (17 | ) | (221 | ) | -0.3 | % | (28 | ) | 0.0 | % | - | - | (28 | ) | - | 0.0 | % | ||||||||||||||||||||||||||||||||||||||
|
Income (loss) before (provision) benefit for income taxes and noncontrolling interest |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5,221 | 6.9 | % | 49 | 5,172 | 7.0 | % | (64,987 | ) | -96.2 | % | (388 | ) | (71,619 | ) | 421 | 6,599 | 10.0 | % | |||||||||||||||||||||||||||||||||||||||||
| (Provision) benefit for income taxes | (1,505 | ) | -2.0 | % | (63 | ) | (1,442 | ) | -1.9 | % | 11,641 | 17.2 | % | 99 | 13,852 | (50 | ) | (2,260 | ) | -3.4 | % | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) | 3,716 | 4.9 | % | (14 | ) | 3,730 | 5.0 | % | (53,346 | ) | -79.0 | % | (289 | ) | (57,767 | ) | 371 | 4,339 | 6.6 | % | |||||||||||||||||||||||||||||||||||||||
| Net (income) loss attributable to noncontrolling interest, net of tax | 6 | 0.0 | % | 6 | - | 0.0 | % | (138 | ) | -0.2 | % | - | - | (138 | ) | - | 0.0 | % | |||||||||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to CRA International, Inc. | $ | 3,722 | 4.9 | % | $ | (8 | ) | $ | 3,730 | 5.0 | % | $ | (53,484 | ) | -79.2 | % | $ | (289 | ) | $ | (57,767 | ) | $ | 233 | $ | 4,339 | 6.6 | % | |||||||||||||||||||||||||||||||
| Net income (loss) per share attributable to CRA International, Inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basic | $ | 0.37 | $ | 0.37 | $ | (5.33 | ) | $ | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | 0.37 | $ | 0.37 | $ | (5.33 | ) | $ | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average number of shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basic | 10,071 | 10,071 | 10,027 | 10,027 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | 10,148 | 10,148 | 10,027 | (4 | ) | 10,127 | (4 | ) | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
(1) These adjustments include activity related to NeuCo in the Company's GAAP results. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
(2) During the fiscal quarter ended December 29, 2012, the Company incurred pre-tax expenses of $1.0 million and related income tax benefit of $0.3 million principally associated with restructuring actions announced in the third quarter of fiscal 2012, partially offset by $0.6 million of pre-tax credits and related income tax provision of $0.2 million principally associated with adjustments to its leased office space in Chicago, IL and Houston, TX. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
(3) As part of its routine annual impairment test in fiscal 2012, the Company determined that it needed to write off a portion of its goodwill. The impairment charge in fiscal 2012 did not affect the Company's liquidity position, cash flow, bank line of credit, or the operations of the Company. Approximately $0.2 million of fees were recorded for professional services rendered in connection with the goodwill impairment analysis. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
(4) Approximately 100,000 common stock equivalents are excluded from the GAAP results because they are antidilutive in the fourth quarter of fiscal 2012 due to the net loss, but they are included in the non-GAAP results because they are dilutive based upon the net income. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CRA INTERNATIONAL, INC. | ||||||||||||||||||||||||||||||||||||||||||||||
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS INCLUDING A RECONCILIATION TO NON-GAAP RESULTS | ||||||||||||||||||||||||||||||||||||||||||||||
| FOR THE FISCAL YEAR ENDED DECEMBER 28, 2013 COMPARED TO THE FISCAL YEAR ENDED DECEMBER 29, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||||||||||||||||||||||||||||||||
| Fiscal Year Ended December 28, 2013 | Fiscal Year Ended December 29, 2012 | |||||||||||||||||||||||||||||||||||||||||||||
|
GAAP |
GAAP % of Revenues |
Adjustments to |
Non-GAAP |
Non-GAAP |
GAAP |
GAAP |
Adjustments to |
Adjustments to |
Adjustments to GAAP Results (NeuCo) (1) |
Non-GAAP Results |
Non-GAAP % of Revenues |
|||||||||||||||||||||||||||||||||||
| Revenues | $ | 278,432 | 100.0 | % | $ | 5,050 | $ | 273,382 | 100.0 | % | $ | 270,390 | 100.0 | % | $ | - | $ | - | $ | 5,460 | $ | 264,930 | 100.0 | % | ||||||||||||||||||||||
| Costs of services | 189,262 | 68.0 | % | 1,365 | 187,897 | 68.7 | % | 182,381 | 67.5 | % | 3,825 | - | 1,314 | 177,242 | 66.9 | % | ||||||||||||||||||||||||||||||
| Gross profit (loss) | 89,170 | 32.0 | % | 3,685 | 85,485 | 31.3 | % | 88,009 | 32.5 | % | (3,825 | ) | - | 4,146 | 87,688 | 33.1 | % | |||||||||||||||||||||||||||||
| Selling, general and administrative expenses | 64,242 | 23.1 | % | 3,608 | 60,634 | 22.2 | % | 67,235 | 24.9 | % | 1,522 | 225 | 3,287 | 62,201 | 23.5 | % | ||||||||||||||||||||||||||||||
| Depreciation and amortization | 6,411 | 2.3 | % | 3 | 6,408 | 2.3 | % | 7,190 | 2.7 | % | 1,381 | - | 4 | 5,805 | 2.2 | % | ||||||||||||||||||||||||||||||
| Goodwill impairment | - | 0.0 | % | - | - | 0.0 | % | 71,394 | 26.4 | % | - | 71,394 | - | - | 0.0 | % | ||||||||||||||||||||||||||||||
| Income (loss) from operations | 18,517 | 6.7 | % | 74 | 18,443 | 6.7 | % | (57,810 | ) | -21.4 | % | (6,728 | ) | (71,619 | ) | 855 | 19,682 | 7.4 | % | |||||||||||||||||||||||||||
| Interest and other income (expense), net | (599 | ) | -0.2 | % | (87 | ) | (512 | ) | -0.2 | % | (213 | ) | -0.1 | % | - | - | (145 | ) | (68 | ) | 0.0 | % | ||||||||||||||||||||||||
|
Income (loss) before (provision) benefit for income taxes and noncontrolling interest |
||||||||||||||||||||||||||||||||||||||||||||||
| 17,918 | 6.4 | % | (13 | ) | 17,931 | 6.6 | % | (58,023 | ) | -21.5 | % | (6,728 | ) | (71,619 | ) | 710 | 19,614 | 7.4 | % | |||||||||||||||||||||||||||
| (Provision) benefit for income taxes | (6,683 | ) | -2.4 | % | (244 | ) | (6,439 | ) | -2.4 | % | 5,180 | 1.9 | % | 968 | 13,852 | (148 | ) | (9,492 | ) | -3.6 | % | |||||||||||||||||||||||||
| Net income (loss) | 11,235 | 4.0 | % | (257 | ) | 11,492 | 4.2 | % | (52,843 | ) | -19.5 | % | (5,760 | ) | (57,767 | ) | 562 | 10,122 | 3.8 | % | ||||||||||||||||||||||||||
| Net (income) loss attributable to noncontrolling interest, net of tax | 135 | 0.0 | % | 135 | - | 0.0 | % | (147 | ) | -0.1 | % | - | - | (147 | ) | - | 0.0 | % | ||||||||||||||||||||||||||||
| Net income (loss) attributable to CRA International, Inc. | $ | 11,370 | 4.1 | % | $ | (122 | ) | $ | 11,492 | 4.2 | % | $ | (52,990 | ) | -19.6 | % | $ | (5,760 | ) | $ | (57,767 | ) | $ | 415 | $ | 10,122 | 3.8 | % | ||||||||||||||||||
| Net income (loss) per share attributable to CRA International, Inc.: | ||||||||||||||||||||||||||||||||||||||||||||||
| Basic | $ | 1.13 | $ | 1.14 | $ | (5.21 | ) | $ | 1.00 | |||||||||||||||||||||||||||||||||||||
| Diluted | $ | 1.12 | $ | 1.13 | $ | (5.21 | ) | $ | 0.98 | |||||||||||||||||||||||||||||||||||||
| Weighted average number of shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||
| Basic | 10,084 | 10,084 | 10,167 | 10,167 | ||||||||||||||||||||||||||||||||||||||||||
| Diluted | 10,173 | 10,173 | 10,167 | (4 | ) | 10,307 | (4 | ) | ||||||||||||||||||||||||||||||||||||||
| (1) These adjustments include activity related to NeuCo in the Company's GAAP results. | ||||||||||||||||||||||||||||||||||||||||||||||
| (2) During the fiscal year ended December 29, 2012, the Company incurred pre-tax expenses of $6.7 million and related income tax benefit of $1.0 million. | ||||||||||||||||||||||||||||||||||||||||||||||
| Of these amounts, $5.4 million of pre-tax expenses and $1.2 million of related income tax benefit were recorded in fiscal 2012 in connection with restructuring actions announced in the third quarter of fiscal 2012. | ||||||||||||||||||||||||||||||||||||||||||||||
|
These actions included the elimination and restructuring of selected practice areas, and reducing selling, general, and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. |
||||||||||||||||||||||||||||||||||||||||||||||
|
The Company also incurred pre-tax expenses of $1.3 million and related income tax provision of $0.2 million in connection with the surrender of a portion of the Company's leased office space in London, England and adjustments related to its leased office space in Chicago, IL and Houston, TX. |
||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
| (3) As part of its routine annual impairment test in fiscal 2012, the Company determined that it needed to write off a portion of its goodwill. The impairment charge in fiscal 2012 did not affect the Company's liquidity position, cash flow, bank line of credit, or the operations of the Company. Approximately $0.2 million of fees were recorded for professional services rendered in connection with the goodwill impairment analysis. | ||||||||||||||||||||||||||||||||||||||||||||||
| (4) Approximately 140,000 common stock equivalents are excluded from the GAAP results because they are antidilutive in the fourth quarter of fiscal 2012 due to the net loss, but they are included in the non-GAAP results because they are dilutive based upon the net income. | ||||||||||||||||||||||||||||||||||||||||||||||
| CRA INTERNATIONAL, INC. | |||||||||
| UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
| (In thousands) | |||||||||
|
December 28, |
December 29, |
||||||||
|
2013 |
2012 |
||||||||
|
Assets |
|||||||||
| Cash and cash equivalents | $ | 51,251 | $ | 55,451 | |||||
| Accounts receivable and unbilled, net | 82,131 | 77,270 | |||||||
| Other current assets | 29,906 | 38,956 | |||||||
| Total current assets | 163,288 | 171,677 | |||||||
| Property and equipment, net | 15,655 | 17,980 | |||||||
| Goodwill and intangible assets, net | 86,110 | 72,599 | |||||||
| Other assets | 54,839 | 29,754 | |||||||
| Total assets | $ | 319,892 | $ | 292,010 | |||||
|
Liabilities and shareholders’ equity |
|||||||||
| Current liabilities | $ | 87,873 | $ | 69,210 | |||||
| Long-term liabilities | 7,382 | 10,566 | |||||||
| Total liabilities | 95,255 | 79,776 | |||||||
| Total shareholders’ equity | 224,637 | 212,234 | |||||||
| Total liabilities and shareholders’ equity | $ | 319,892 | $ | 292,010 | |||||
| CRA INTERNATIONAL, INC. | ||||||||||||||||||||||||||||||||||||||
| UNAUDITED ADJUSTED EBITDA INCLUDING A RECONCILIATION TO NON-GAAP ADJUSTED EBITDA | ||||||||||||||||||||||||||||||||||||||
| FOR THE FISCAL QUARTER AND YEAR ENDED DECEMBER 28, 2013 COMPARED TO THE FISCAL QUARTER AND YEAR ENDED DECEMBER 29, 2012 | ||||||||||||||||||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||||||||||||||||
| Quarter Ended December 28, 2013 | Quarter Ended December 29, 2012 | |||||||||||||||||||||||||||||||||||||
|
GAAP |
GAAP |
Adjustments to |
Non-GAAP |
Non-GAAP |
GAAP |
GAAP |
Adjustments to GAAP Results Restructuring (2) |
Adjustments to |
Adjustments to |
Non-GAAP |
Non-GAAP |
|||||||||||||||||||||||||||
| Income (loss) from operations | $ | 5,459 | 7.2 | % | $ | 66 | $ | 5,393 | 7.3 | % | $ | (64,959 | ) | -96.2 | % | $ | (388 | ) | $ | (71,619 | ) | $ | 449 | $ | 6,599 | 10.0 | % | |||||||||||
| Depreciation and amortization | 1,619 | 2.1 | % | - | 1,619 | 2.2 | % | 1,610 | 2.4 | % | 207 | - | 1 | 1,402 | 2.1 | % | ||||||||||||||||||||||
| Goodwill impairment | - | 0.0 | % | - | - | 0.0 | % | 71,394 | 105.7 | % | - | 71,394 | - | - | 0.0 | % | ||||||||||||||||||||||
| EBITDA | 7,078 | 9.4 | % | 66 | 7,012 | 9.4 | % | 8,045 | 11.9 | % | (181 | ) | (225 | ) | 450 | 8,001 | 12.1 | % | ||||||||||||||||||||
| Share-based compensation expenses | 882 | 1.2 | % | - | 882 | 1.2 | % | 1,157 | 1.7 | % | - | - | - | 1,157 | 1.8 | % | ||||||||||||||||||||||
| Amortization of forgivable loans | 3,970 | 5.2 | % | - | 3,970 | 5.3 | % | 1,825 | 2.7 | % | 226 | - | - | 1,599 | 2.4 | % | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 11,930 | 15.8 | % | $ | 66 | $ | 11,864 | 16.0 | % | $ | 11,027 | 16.3 | % | $ | 45 | $ | (225 | ) | $ | 450 | $ | 10,757 | 16.3 | % | |||||||||||||
| Year to Date Period Ended December 28, 2013 | Year to Date Period Ended December 29, 2012 | |||||||||||||||||||||||||||||||||||||
| GAAP Year to Date Period Ended December 28, 2013 |
GAAP % of Revenues |
Adjustments to GAAP Results NeuCo (1) |
Non-GAAP Year to Date Period Ended December 28, 2013 |
Non-GAAP % of Revenues |
GAAP Year to Date Period Ended December 29, 2012 |
GAAP % of Revenues |
Adjustments to GAAP Results Restructuring (2) |
Adjustments to GAAP Results Goodwill Impairment (3) |
Adjustments to GAAP Results NeuCo (1) |
Non-GAAP Year to Date Period Ended December 29, 2012 |
Non-GAAP % of Revenues |
|||||||||||||||||||||||||||
| Income (loss) from operations | $ | 18,517 | 6.7 | % | $ | 74 | $ | 18,443 | 6.7 | % | $ | (57,810 | ) | -21.4 | % | $ | (6,728 | ) | $ | (71,619 | ) | $ | 855 | $ | 19,682 | 7.4 | % | |||||||||||
| Depreciation and amortization | 6,411 | 2.3 | % | 3 | 6,408 | 2.3 | % | 7,190 | 2.7 | % | 1,381 | - | 4 | 5,805 | 2.2 | % | ||||||||||||||||||||||
| Goodwill impairment | - | 0.0 | % | - | - | 0.0 | % | 71,394 | 26.4 | % | - | 71,394 | - | - | 0.0 | % | ||||||||||||||||||||||
| EBITDA | 24,928 | 9.0 | % | 77 | 24,851 | 9.1 | % | 20,774 | 7.7 | % | (5,347 | ) | (225 | ) | 859 | 25,487 | 9.6 | % | ||||||||||||||||||||
| Share-based compensation expenses | 3,035 | 1.1 | % | - | 3,035 | 1.1 | % | 4,947 | 1.8 | % | - | - | - | 4,947 | 1.9 | % | ||||||||||||||||||||||
| Amortization of forgivable loans | 14,194 | 5.1 | % | - | 14,194 | 5.2 | % | 6,317 | 2.3 | % | 226 | - | - | 6,091 | 2.3 | % | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 42,157 | 15.1 | % | $ | 77 | $ | 42,080 | 15.4 | % | $ | 32,038 | 11.8 | % | $ | (5,121 | ) | $ | (225 | ) | $ | 859 | $ | 36,525 | 13.8 | % | ||||||||||||
| (1) These adjustments include activity related to NeuCo in the Company's GAAP results. | ||||||||||||||||||||||||||||||||||||||
| (2) During the fiscal quarter ended December 29, 2012, the Company incurred pre-tax expenses of $1.0 million and related income tax benefit of $0.3 million principally associated with restructuring actions announced in the third quarter of fiscal 2012, partially offset by $0.6 million of pre-tax credits and related income tax provision of $0.2 million principally associated with adjustments to its leased office space in Chicago, IL and Houston, TX. | ||||||||||||||||||||||||||||||||||||||
| During the fiscal year ended December 29, 2012, the Company incurred pre-tax expenses of $6.7 million and related income tax benefit of $1.0 million. | ||||||||||||||||||||||||||||||||||||||
| Of these amounts, $5.4 million of pre-tax expenses and $1.2 million of related income tax benefit were recorded in fiscal 2012 in connection with restructuring actions announced in the third quarter of fiscal 2012. | ||||||||||||||||||||||||||||||||||||||
|
These actions included the elimination and restructuring of selected practice areas, and reducing selling, general, and administrative costs. In connection with the restructuring plan, the Company eliminated its Chemicals practice and closed its Middle East operations. |
||||||||||||||||||||||||||||||||||||||
|
The Company also incurred pre-tax expenses of $1.3 million and related income tax provision of $0.2 million in connection with the surrender of a portion of the Company's leased office space in London, England and adjustments related to its leased office space in Chicago, IL and Houston, TX. |
||||||||||||||||||||||||||||||||||||||
| (3) As part of its routine annual impairment test in fiscal 2012, the Company determined that it needed to write off a portion of its goodwill. The impairment charge in fiscal 2012 did not affect the Company's liquidity position, cash flow, bank line of credit, or the operations of the Company. Approximately $0.2 million of fees were recorded for professional services rendered in connection with the goodwill impairment analysis. | ||||||||||||||||||||||||||||||||||||||
| CRA INTERNATIONAL, INC. | |||||||||||
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
| (In thousands) | |||||||||||
| Fiscal Year Ended | Fiscal Year Ended | ||||||||||
| December 28, | December 29, | ||||||||||
| 2013 | 2012 | ||||||||||
| Operating activities: | |||||||||||
| Net income (loss) | $ | 11,235 | $ | (52,843 | ) | ||||||
| Adjustments to reconcile net income (loss) | |||||||||||
| to net cash used in operating activities, | |||||||||||
| net of effect of acquired businesses: | |||||||||||
| Non-cash items, net | 4,473 | 72,002 | |||||||||
| Accounts receivable and unbilled services | 6,920 | 5,597 | |||||||||
| Working capital items, net | (4,180 | ) | (33,281 | ) | |||||||
| Net cash provided by (used in) operating activities | 18,448 | (8,525 | ) | ||||||||
| Investing activities: | |||||||||||
| Consideration relating to acquisitions, net | (15,591 | ) | - | ||||||||
| Purchase of property and equipment | (2,816 | ) | (2,732 | ) | |||||||
| Sale of investments | - | 23,989 | |||||||||
| Purchase of investments | - | (9,494 | ) | ||||||||
| Collections on notes receivable | 14 | 989 | |||||||||
| Net cash (used in) provided by investing activities | (18,393 | ) | 12,752 | ||||||||
| Financing activities: | |||||||||||
| Issuance of common stock, principally stock option exercises | 207 | 647 | |||||||||
| Payments on notes payable | (700 | ) | (650 | ) | |||||||
| Borrowings under line of credit | 17,320 | - | |||||||||
| Repayments under line of credit | (17,320 | ) | - | ||||||||
| Tax withholding payments reimbursed by restricted shares | (730 | ) | (1,360 | ) | |||||||
| Excess tax benefits from share-based compensation | 7 | 81 | |||||||||
| Repurchase of common stock | (2,190 | ) | (9,062 | ) | |||||||
| Debt issuance costs | (1,120 | ) | - | ||||||||
| Net cash used in financing activities | (4,526 | ) | (10,344 | ) | |||||||
| Effect of foreign exchange rates on cash and cash equivalents | 271 | (19 | ) | ||||||||
| Net decrease in cash and cash equivalents | (4,200 | ) | (6,136 | ) | |||||||
| Cash and cash equivalents at beginning of period | 55,451 | 61,587 | |||||||||
| Cash and cash equivalents at end of period | $ | 51,251 | $ | 55,451 | |||||||
| Supplemental cash flow information: | |||||||||||
| Cash paid for income taxes | $ | 2,887 | $ | 8,718 | |||||||
| Cash paid for interest | $ | 339 | $ | 223 | |||||||
Source:
Charles River Associates
Wayne D. Mackie, 617-425-3740
Executive Vice President, CFO
or
Sharon Merrill Associates, Inc.
Dennis Walsh, 617-542-5300
Vice President